Study guide
4.2 Management of Patients with Cardiovascular, Respiratory & Renal Diseases
Australian Dental Council ADC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Examination Overview
1.1 ADC Written Examination Structure, Scoring Clusters & Australian Practice Context 1.2 Clinical Scenario Reasoning & Australian Therapeutic Guidelines Alignment
2 Chapter 2: Restorative Dentistry & Fixed Prosthodontics
2.1 Minimal Intervention Dentistry, Caries Risk & Lesion Management 2.2 Direct Restorative Materials, Resin Composites & Dental Amalgam 2.3 Indirect Restorations, Crown Preparation, Veneers & Onlays 2.4 Dental Adhesion, Etch-and-Rinse vs Self-Etch Systems & Hybrid Layer 2.5 Diagnosis & Management of Tooth Wear (Erosion, Attrition, Abrasion, Abfraction)
3 Chapter 3: Dental Pharmacology & Therapeutic Guidelines
3.1 Local Anaesthetic Agents, Vasoconstrictors & Injection Techniques 3.2 Dental Analgesia Protocols, NSAIDs, Paracetamol & Opioid Stewardship 3.3 Dental Antibiotic Prescribing, Prophylaxis & Therapeutic Guidelines 3.4 Management of Patients on Anticoagulants & Antiplatelet Therapy 3.5 Medication-Related Osteonecrosis of the Jaw (MRONJ) Risk & Management
4 Chapter 4: General Medicine & Medically Compromised Patients
4.1 Dental Office Medical Emergencies, Anaphylaxis & Resuscitation Protocols 4.2 Management of Patients with Cardiovascular, Respiratory & Renal Diseases 4.3 Special Needs Dentistry, Geriatric Care & Dental Management in Pregnancy 4.4 Infective Endocarditis Prophylaxis & Cardiac Risk Assessment
5 Chapter 5: Oral Medicine & Oral Pathology
5.1 Ulcerative, Vesiculobullous & Immune-Mediated Oral Mucosal Diseases 5.2 Oral Potentially Malignant Disorders (OPMDs) & Oral Cancer Screening 5.3 Salivary Gland Disorders, Sialadenitis & Cysts of the Jaws 5.4 Oral Biopsy Indications, Diagnostic Pathways & Specialist Referral
6 Chapter 6: Endodontics
6.1 Pulpal and Periapical Diagnostic Classification & Diagnostic Testing 6.2 Canal Instrumentation, Working Length & Irrigation Protocols 6.3 Root Canal Obturation, Endodontic Retreatment & Failure Analysis 6.4 Endodontic Management of Traumatic Dental Injuries & Vital Pulp Therapy
7 Chapter 7: Oral Surgery
7.1 Surgical & Simple Exodontia Techniques & Intraoperative Complications 7.2 Assessment & Surgical Management of Impacted Third Molars 7.3 Oroantral Communication, Displacement & Trigeminal Nerve Injury Prevention 7.4 Management of Spreading Odontogenic Infections & Fascial Space Abscesses
8 Chapter 8: Paediatric Dentistry & Orthodontics
8.1 Primary Tooth Pulpotomy, Pulpectomy & Stainless Steel Crown Restoration 8.2 Early Childhood Caries, Space Maintenance & Traumatic Primary Dentition 8.3 Malocclusion Classification, Etiology & Interceptive Orthodontic Management 8.4 Non-Pharmacological Behaviour Guidance, Child Protection & Consent
9 Chapter 9: Periodontics
9.1 2018 Periodontal Staging, Grading & Risk Factor Assessment 9.2 Subgingival Debridement, Plaque Control & Antimicrobial Adjuncts 9.3 Periodontal Surgical Flaps, Regenerative Therapy & Furcation Management 9.4 Supportive Periodontal Care, Maintenance Protocols & Risk Re-evaluation
10 Chapter 10: Preventive Dentistry
10.1 Caries Risk Assessment Models (CAMBRA) & Personalised Prevention 10.2 Fluoride Mechanisms, Topical Applications & Community Fluoridation 10.3 Dietary Counselling, Stephan Curve Dynamics & Erosion Prevention 10.4 Pit and Fissure Sealants, Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP)
11 Chapter 11: Dental Emergencies
11.1 Emergency Management of Severe Odontogenic Pain & Acute Irreversible Pulpitis 11.2 Acute Management of Avulsed, Luxated & Fractured Permanent Teeth 11.3 Diagnosis, Differentiation & Treatment of Cracked Tooth Syndrome 11.4 Emergency Management of Post-Extraction Hemorrhage & Acute Abscesses
12 Chapter 12: Pain & Behaviour Management
12.1 Assessment & Management of Dental Anxiety, Phobia & Dental Fear 12.2 Nitrous Oxide Inhalation Sedation & Intravenous Sedation Guidelines 12.3 Diagnosis & Management of Temporomandibular Disorders & Chronic Facial Pain 12.4 Informed Consent, Patient Autonomy, Ethics & Professional Boundaries
13 Chapter 13: Removable Prosthodontics
13.1 Complete Denture Design, Impression Techniques & Maxillomandibular Relations 13.2 Removable Partial Denture Design, Surveying, Clasping & RPI System 13.3 Post-Insertion Problems, Sore Spots, Relining & Rebase Procedures 13.4 Denture Stomatitis, Tissue Conditioning & Pre-Prosthetic Surgery
14 Chapter 14: Dental Radiography & Imaging
14.1 Radiation Physics, ALARA Principles, Shielding & Dose Reduction 14.2 Intraoral Radiographic Techniques, Positioning & Geometry 14.3 Radiographic Interpretation, Normal Anatomical Landmarks & Artifacts
15 Chapter 15: Infection Prevention & Control
15.1 Standard & Transmission-Based Precautions in Dental Practice 15.2 Instrument Reprocessing, Autoclaving & Sterilisation Monitoring 15.3 Dental Unit Waterlines, Waste Management & Occupational Exposure Protocols
16 Chapter 16: Dental Implants & Peri-Implant Diseases
16.1 Patient Selection, Bone Density, Anatomic Constraints & Prosthetic Planning 16.2 Peri-Implant Anatomy, Hygiene Protocols & Maintenance Monitoring 16.3 Diagnosis, Risk Factors & Management of Peri-Implant Diseases
4.2 Management of Patients with Cardiovascular, Respiratory & Renal Diseases
Key Takeaways Explain This Topic AI
Elective dental procedures must be deferred if pre-operative blood pressure exceeds 180/110 mmHg, requiring immediate medical evaluation.
For patients with significant cardiovascular disease (NYHA Class III/IV, unstable angina, recent MI <6 months), exogenous adrenaline in local anaesthetic should be capped at 0.04 mg (approx. 2 cartridges of 1:100,000 adrenaline).
Patients taking non-selective beta-blockers (e.g., propranolol) risk severe acute hypertension and reflex bradycardia if given high doses of adrenaline, due to unopposed alpha-1 vasoconstriction.
Chronic obstructive pulmonary disease (COPD) patients should be treated in an upright or semi-recumbent position and high-flow oxygen avoided to prevent suppressing their hypoxic respiratory drive.
Patients undergoing chronic haemodialysis should receive elective dental treatment on the day AFTER dialysis to ensure systemic heparin has cleared and metabolic stability is optimal.
Last updated: August 2026
4.2 Management of Patients with Cardiovascular, Respiratory & Renal Diseases
Treating medically compromised patients requires thorough pre-operative risk assessment, tailored dental management strategies, and an understanding of systemic drug interactions. Dental practitioners must evaluate organ reserve, modify treatment parameters (such as appointment duration, patient positioning, and local anaesthetic selection), and recognize when elective dental treatment must be deferred.
Cardiovascular Diseases in Dental Practice
Cardiovascular conditions represent the most prevalent medical complexity encountered in adult dental populations. Stress management protocols and vasoconstrictor limits are central to safe care.
Hypertension Classification & Dental Cut-Off Guidelines
- Blood Pressure Category Systolic (mmHg) Diastolic (mmHg) Dental Management Protocol
- Optimal <120 <80 Routine dental care
- Normal 120 – 129 80 – 84 Routine dental care; lifestyle advice
- High-normal 130 – 139 85 – 89 Routine care; inform patient and encourage GP review
- Grade 1 (mild) hypertension 140 – 159 90 – 99 Routine care with stress reduction; advise GP follow-up
Grade 2 (moderate) hypertension 160 – 179 100 – 109 Consider deferring elective care if poorly controlled; medical advice
- Grade 3 (severe) hypertension ≥180 ≥110 Defer elective care; urgent medical referral
- Ischaemic Heart Disease (IHD)
Stable Angina : Chest pain predictably induced by exertion and relieved by rest or sublingual GTN. Protocol: Short morning appointments, stress reduction, keep GTN spray on the dental bracket table. Vasoconstrictor cap: Max 0.04 mg adrenaline (approx. 2 cartridges of 1:100,000 adrenaline).
Unstable Angina / Recent Myocardial Infarction (<6 months) : High risk for re-infarction or fatal arrhythmia. Defer all elective dental care for a minimum of 6 months (or 3–6 months with cardiology clearance). Emergency treatment should be conservative and performed in a hospital dental facility if required.
Drug Interaction Warning — Non-Selective Beta-Blockers : Patients taking non-selective beta-blockers (e.g., Propranolol) experience unopposed α 1 \alpha_1 α 1 -adrenergic vasoconstriction when exogenous adrenaline is administered, precipitating acute severe hypertension accompanied by compensatory reflex bradycardia. Limit adrenaline strictly to ≤ 0.04 mg \le 0.04\text{ mg} ≤ 0.04 mg or use Prilocaine with Felypressin / Mepivacaine Plain.
Heart Failure & New York Heart Association (NYHA) Staging
NYHA Class I / II : Mild dyspnoea on heavy exertion. Routine care with stress reduction.
NYHA Class III / IV : Dyspnoea on minimal exertion or at rest. Intolerant of supine position ( orthopnea and paroxysmal nocturnal dyspnoea). Treatment Protocol: Seat patient in an upright or semi-recumbent position ; avoid fluid overload during ultrasonic scaling; cap adrenaline at 0.04 mg.
Cardiac Pacemakers & Implantable Cardioverter-Defibrillators (ICDs) : Modern bipolar pacemakers and ICDs are well-shielded against electromagnetic interference (EMI). Contemporary piezo-electric ultrasonic scalers and curing lights are safe, though older unshielded magnetostrictive units should be kept at least 30 cm away from the cardiac generator.
Respiratory Diseases
Respiratory compromise impairs oxygen delivery and hypercapnic clearance, influencing local anaesthetic and sedative selection.
Asthma Management in Dentistry
Pre-operative Assessment : Identify frequency of attacks, hospitalisations, and triggers (cold air, anxiety, allergens, exercise).
Pharmacological Hazards :
NSAIDs & Aspirin : Contraindicated in patients with Aspirin-Exacerbated Respiratory Disease (AERD / Samter's Triad). NSAIDs cause COX-1 inhibition, shunting arachidonic acid into the 5-lipoxygenase pathway and triggering severe leukotriene-mediated bronchospasm.
Sodium Metabisulfite : Preservative in adrenaline-containing local anaesthetics; can trigger asthmatic reactions in sulfite-sensitive patients.
Macrolides & Theophylline : Erythromycin and Clarithromycin inhibit hepatic CYP1A2, elevating plasma Theophylline to toxic levels (arrhythmias, seizures).
Protocol : Instruct patients to bring their rescue bronchodilator (Salbutamol) to every appointment. Pre-treatment inhalation of 2 puffs of Salbutamol prior to invasive procedures prevents stress-induced bronchospasm.
Chronic Obstructive Pulmonary Disease (COPD)
COPD comprises chronic bronchitis and emphysema, resulting in irreversible airway obstruction.
Pathophysiology of Hypoxic Drive : Long-standing hypercapnia (high P a C O 2 PaCO_2 P a C O 2 ) desensitises central chemoreceptors. Breathing becomes driven by peripheral chemoreceptors responsive to hypoxia ( P a O 2 PaO_2 P a O 2 ). Administering high-flow oxygen (>2–3 L/min) abolishes this hypoxic drive, causing severe respiratory depression and carbon dioxide narcosis.
Dental Management Parameters :
Seat patient upright or semi-recumbent to optimize diaphragmatic excursion.
Avoid rubber dam if it exacerbates feelings of suffocation.
Avoid central nervous system depressants (opioids, benzodiazepines, barbiturates).
Nitrous oxide inhalation sedation is relatively contraindicated in severe bullous emphysema due to expansion of air spaces.
Renal Disease & End-Stage Renal Disease (ESRD)
Chronic Kidney Disease (CKD) impairs excretion of metabolic waste and drugs, alters haemostasis, and requires specific scheduling around renal replacement therapy. +---------------------------------------------------------------------------------------------------+
- | CKD STAGING BY eGFR (mL/min/1.73m²) |
- | |
- | Stage 1: Normal (eGFR ≥90) =======> Standard Dental Care |
- | Stage 2: Mild (eGFR 60-89) =======> Standard Care; monitor drug dosing |
- | Stage 3: Moderate (eGFR 30-59) =======> Dose adjustment for renally cleared drugs |
- | Stage 4: Severe (eGFR 15-29) =======> AVOID NSAIDs; consult nephrologist |
- | Stage 5: Failure / ESRD (eGFR <15) =======> Dialysis timing protocol; extreme bleeding risk |
- +---------------------------------------------------------------------------------------------------+
- Pathophysiological Sequelae of ESRD
Uremic Bleeding Diathesis : Accumulation of uremic toxins impairs platelet adhesion and aggregation (dysfunctional von Willebrand factor binding to platelet glycoprotein IIb/IIIa receptors), causing prolonged bleeding times despite a normal platelet count.
Renal Osteodystrophy : Hyperphosphatemia and hypocalcemia trigger secondary hyperparathyroidism, producing widespread bone resorption, loss of lamina dura, and brown tumours of the jaws.
Renal Anemia : Decreased erythropoietin production by juxtaglomerular cells leads to normocytic normochromic anemia, impairing tissue healing.
Haemodialysis Dental Management Protocol
Appointment Timing (CRITICAL) : Perform elective dental treatment on the DAY AFTER haemodialysis (e.g., Tuesday or Thursday for a Mon/Wed/Fri dialysis regimen).
Rationale : On the day of dialysis, the patient receives systemic Heparin (high bleeding risk) and suffers metabolic fatigue. On the day after, circulating heparin has cleared (half-life ~1–2 hours), fluid and electrolyte balances are optimal, and uremic toxins are minimal.
Arteriovenous (AV) Fistula Protection : NEVER take blood pressure measurements or place intravenous lines on the arm containing an AV fistula or graft, as pressure can cause thrombosis and permanent shunt failure.
Nephrotoxic Drug Avoidance : NSAIDs (Ibuprofen, Naproxen, Ketorolac) are strictly contraindicated in severe renal impairment (eGFR < 30 mL/min <30\text{ mL/min} < 30 mL/min ) as they cause acute tubular necrosis and inhibit renal prostaglandin-mediated perfusion.